MVision AI receives TGA approval and market authorization for Australia
HELSINKI, Finland – May 1, 2024 An application for MVision AI Segmentation (Contour+) has been submitted and accepted by the Therapeutic Goods Administration (TGA) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation therapy treatment planning workflows. Contour+ accelerates the contouring process, provides guidance toward standardization, enhances consistency, and […]
Dharanipathy Rangaraj Appointed as CEO of MVision AI
Helsinki, Uusimaa – April 29, 2024 – MVision AI, a pioneering company in developing innovative AI solutions in the radiation oncology & imaging space, proudly announces the appointment of Dharanipathy Rangaraj as its new Chief Executive Officer (CEO). In his new capacity as CEO of MVision AI, Dharani will spearhead the company’s mission of developing […]
MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON)
Finland, Helsinki, February 19, 2024 The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI’s successful award of the tender from the Republic of Ireland’s Health Service Executive […]
MVision AI Announces Partnership with Medron Medical Systems (Canada)
HELSINKI, Finland – January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL) approval from Health Canada. The […]
The world’s first comprehensive GBS™ solution for radiation therapy cancer treatment is now available for implementation in Canadian clinics
HELSINKI, Finland – January 22, 2024 MVision AI announces first Health Canada Medical Device License for MVision AI Segmentation (Contour+). In conjunction with Guide and Verify, Contour+ stands as a unique solution covering all the essential needs of radiotherapy departments, offering a more comprehensive approach to staff training and patient treatment plans. According to the […]
The voice of customer experience: Dr. Giuseppe Sasso, New Zealand
Dr. Giuseppe Sasso is a Radiation Oncologist with extensive experience in the field, who has been using MVision AI for more than a year already, as an individual customer. He graduated from University of Naples where he also finished residency training 25 years ago. Since then, he has treated patients in multiple clinics from Italy, […]
Merging (Artificial) Intelligence and Ethics in Radiation Oncology – Why and How?
”Our future is a race between the growing power of technology and the wisdom with which we use it.” This statement of Stephen Hawking, the well known physicist, mathematician and visionary, summarizes very well the present challenges. A new technology, irrespective of its degree of complexity, makes an impact in our world depending on the […]
LEARN. PREVENT. SCREEN. CERVICAL CANCER CAN BECOME HISTORY.
January is Cervical Cancer Awareness Month, and these three core principles are emphasized during the 2024 campaign. Nowadays, cervical cancer is responsible for more than 300,000 deaths each year globally. Fortunately, we have the tools to prevent it, diagnose it early, and treat it efficiently in most cases. This is why we need to become […]
AI-based auto-contouring – What to expect?
Time is money but it’s even more than that – time is life. Radiotherapy is one of the medical fields in which technological advances find a proper receptor. We find new ways to use outstanding computer capabilities to increase the quality of services and focus on the next steps to increase the quality of care. […]
Lymph nodes irradiation for breast cancer – outlines from the Early Breast Cancer Trialists’ Collaborative Group meta-analysis
An important article for clinical practice was recently published in “The Lancet”. The conclusions are based on the meta-analysis of 16 trials and represents a trustable proof on impact of radiotherapy of the lymph node regions in breast cancer radiotherapy. It is important to mention that individual patient data from 14 324 women was analyzed, […]
MVision AI and Institut de Cancérologie de Lorraine (ICL, Nancy) announce the first installation of unique Guide and Verify solutions for cancer treatment in France
HELSINKI, Finland – November 24, 2023 Institut de CancĂ©rologie de Lorraine (ICL) in Nancy (France) has been a MVision AI customer since the installation of Contour+ in January 2023. This year, the values of using Guideline-Based AI Segmentation in daily practice have been prominently featured in several French media outlets [1], thanks to the efforts […]
The future of AI in Radiotherapy, and how does MVision AI plan to further enhance its offerings in this field
The interview of Jarkko Niemelä, CEO, and Co-founder of MVision AI, for IntelligentHealth.tech magazine. October 2023. What specific challenges does Contour+ address in the field of radiotherapy, and how does its AI-powered automation contribute to overcoming these challenges? The largest challenge in cancer radiotherapy is the shortage of experts, including oncologists. For this reason they […]
